DMAAR — DRUGS MADE IN AMER ACQUTN CO

Ownership history in Alpine Global Management, LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which Alpine Global Management, LLC reported a position in DRUGS MADE IN AMER ACQUTN CO (DMAAR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2025 Q3)
Avg. % of fund
0.01%
First filed
2025 Q3
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 362,500 — 0% 0.01% $68K —
2025 Q3 INITIATED 362,500 — — 0.01% $79K —
% of Fund (quarterly)    DMAAR price (monthly, adj. close)

Other funds also holding DMAAR

As of 2025 Q4 — sorted by position size

HEIGHTS CAPITAL MANAGEMENT, INC 0.01% MANGROVE PARTNERS IM, LLC 3Y 7Y 0.01% Bulldog Investors, LLP 3Y 7Y 0.01% HIGHBRIDGE CAPITAL MANAGEMENT LLC 3Y 7Y 0.01% Polar Asset Management Partners Inc. 3Y 7Y 0.0% RIVERNORTH CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% ARISTEIA CAPITAL, L.L.C. 3Y 7Y 0.0% Shaolin Capital Management LLC 3Y 0.0% Westchester Capital Management, LLC 3Y 7Y 0.0% Radcliffe Capital Management, L.P. 3Y 7Y 0.0%
← Back to Alpine Global Management, LLC Holdings